Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators. Turpie AG, et al. Among authors: bauer ka. Lancet. 2009 May 16;373(9676):1673-80. doi: 10.1016/S0140-6736(09)60734-0. Epub 2009 May 4. Lancet. 2009. PMID: 19411100 Clinical Trial.
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.
Turpie AG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kälebo P, Misselwitz F, Gent M; OdiXa-Knee Study Group. Turpie AG, et al. Among authors: bauer ka. J Thromb Haemost. 2005 Nov;3(11):2479-86. doi: 10.1111/j.1538-7836.2005.01602.x. J Thromb Haemost. 2005. PMID: 16241946 Free article. Clinical Trial.
Fondaparinux, the first selective factor Xa inhibitor.
Turpie AG, Eriksson BI, Lassen MR, Bauer KA. Turpie AG, et al. Among authors: bauer ka. Curr Opin Hematol. 2003 Sep;10(5):327-32. doi: 10.1097/00062752-200309000-00001. Curr Opin Hematol. 2003. PMID: 12913785 Review.
319 results